Accéder au contenu
Merck

[Pharmacological correction of the cytogenetic effects of cisplatin].

Eksperimental'naia i klinicheskaia farmakologiia (2011-01-25)
O L Voronova, O V Neupokoeva, E P Fedorova, A E Prosenko, A A Churin
RÉSUMÉ

Beginning with the first hours of experiments, cisplatin evoked an increase of chromosomal aberrations in CBA/CaLac bone marrow cells. Significant increase of structural infringements of chromosomes due to chromatid breaks was revealed in metaphase plates of murine bone marrow preparations through 24 h after cisplatin intraperitoneal introduction. In late terms of research (90th day), the high level of aberrations of chromosomes was retained. The most pronounced correction of cisplatin mutagenicity was achieved using a preliminary course of thiophan introduction.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Tetrahydrothiophène, 99%